Australia has implemented a high‐coverage HPV vaccination program but has not, to date,
established the distribution of HPV types that occur in cervical cancers in Australia. This …

Background Recent evidence suggests that two doses of HPV vaccines may be as
protective as three doses in the short-term. We estimated the incremental cost-effectiveness …

Background Human papillomavirus (HPV) causes two types of external genital lesions
(EGLs) in men: genital warts (condyloma) and penile intraepithelial neoplasia (PeIN) …

Background Denmark introduced the quadrivalent human papillomavirus vaccine into the
vaccination program for 12-to 15-year-old girls in 2008 to 2009. In 2012, the program was …

Background: Human papillomavirus (HPV) vaccination of girls will have relatively little effect
on HPV-related disease in men who have sex with men (MSM). We determined HPV …

Background Middle school students are recommended as the primary target population for
human papillomavirus (HPV) vaccination. This study aimed to assess HPV and HPV vaccine …

Human papillomavirus (HPV) is one of the most widespread human pathogens. For a long
time, it was treated as an opportunistic infection, but it is in actuality one of the most …

Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …

Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

The use of vaccines to prevent diseases in children, adults, and the elderly results in fewer
medical visits, diagnostic tests, treatments, and hospitalisations, which leads to substantial …